Clinical Trials Insight: 700046940
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2009
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- 16 Jul 2009 To date, 201 patients have been enrolled at eight sites.
- 16 Jul 2009 New trial record.